You have accessJournal of UrologyCME1 May 2022MP50-08 THE PROGNOSTIC SIGNIFICANCE OF LYMPH NODE DISSECTION IN PATIENTS WITH NON-METASTATIC RENAL CELL CARCINOMA WHO UNDERWENT CURATIVE NEPHRECTOMY: A RETROSPECTIVE, LONG-TERM FOLLOW-UP, MULTICENTER STUDY CARCINOMA (NMRCC) WHO UNDERWENT CURATIVE NEPHRECTOMY Sung Han Kim, Jinsoo Chung, Hyung Ho Lee, Boram Park, Seok Soo Byun, Chang Wook Chung, Sung Hoo Hong, Eu Chang Hwang, and Cheol Kwack Sung Han KimSung Han Kim More articles by this author , Jinsoo ChungJinsoo Chung More articles by this author , Hyung Ho LeeHyung Ho Lee More articles by this author , Boram ParkBoram Park More articles by this author , Seok Soo ByunSeok Soo Byun More articles by this author , Chang Wook ChungChang Wook Chung More articles by this author , Sung Hoo HongSung Hoo Hong More articles by this author , Eu Chang HwangEu Chang Hwang More articles by this author , and Cheol KwackCheol Kwack More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002625.08AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: To evaluate the prognostic impact of lymph node dissection (LND) on recurrence-free survival (RFS), overall survival (OS), and cancer-specific survival (CSS) in patients with non-metastatic renal cell carcinoma (nmRCC) who underwent curative nephrectomy. METHODS: A retrospective, five-center study of 1328 nmRCC patients was performed between 2000 and 2012, and the patients were followed up until the end of 2018. Survival measures were compared according to the performance of the LND (LND vs. no LND groups) and the presence of node positivity (N+ and N- groups), while Kaplan-Meier analysis with the log-rank test and Cox regression analysis was used to determine the prognostic risk factors for each survival measure. RESULTS: During the median 55.8-month follow-up, 405 (30.5%) recurrences, 207 (15.6%) deaths, including 189 (14.0%) cancer-specific deaths, were recorded. The risk factor analyses showed that predictive factors for CSS and OS were similar, such as pathologic and clinical T stage, nuclear grade, European Cooperative Oncology Group Score, and albumin, neutrophil, and lymphocyte levels. Meanwhile, sarcomatoid differentiation was found as an additional predictive factor for CSS, while nephrectomy type and diabetes were found as additional predictive factors for OS (p<0.05). For RFS, additional factors such as sarcomatoid differentiation, necrosis, and lymphovascular invasion were present and significant (p<0.05). After adjusting for significant clinicopathological factors affecting survival outcomes considering the hazard ratios of each group in the multivariate analysis, the LND N+ group showed significantly worse prognoses for all survival types (p<0.05). Meanwhile, in the no-LND and LND without positive nodal groups, there was no significant difference between any survival type. (p>0.05). CONCLUSIONS: This study showed that nodal positivity significantly affected RFS, whereas LND significantly affected OS and CSS, in patients with nmRCC who underwent curative nephrectomy. Source of Funding: None © 2022 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 207Issue Supplement 5May 2022Page: e867 Advertisement Copyright & Permissions© 2022 by American Urological Association Education and Research, Inc.MetricsAuthor Information Sung Han Kim More articles by this author Jinsoo Chung More articles by this author Hyung Ho Lee More articles by this author Boram Park More articles by this author Seok Soo Byun More articles by this author Chang Wook Chung More articles by this author Sung Hoo Hong More articles by this author Eu Chang Hwang More articles by this author Cheol Kwack More articles by this author Expand All Advertisement PDF DownloadLoading ...